Published in AIDS on June 01, 2012
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis (2015) 1.76
Fractures after antiretroviral initiation. AIDS (2012) 1.21
Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94
Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women. Osteoporos Int (2012) 0.82
HIV and its effects on bone: a primer for rheumatologists. Curr Opin Rheumatol (2012) 0.80
Tenofovir and bone health. Curr Opin HIV AIDS (2016) 0.78
Comparison of peripheral forearm DXA and clinical risk factor screening using FRAX® to assess the risk of HIV-associated low bone mass: a cross-sectional study. Arch Osteoporos (2014) 0.78
Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK. Int J STD AIDS (2013) 0.77
Factors associated with fractures in HIV-infected persons: which factors matter? Osteoporos Int (2016) 0.75
Primary care of women aging with HIV. J Midwifery Womens Health (2015) 0.75
Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update. Can J Gastroenterol (2013) 0.75
Recovery of Bone Mineral Density Following Discontinuation of Tenofovir-Based HIV Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr (2017) 0.75
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med (2014) 3.48
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr (2009) 2.75
Risk of leukemia as a result of community exposure to gasoline vapors: a follow-up study. Environ Res (2011) 2.65
Asbestos fiber concentrations in the lungs of brake repair workers: commercial amphiboles levels are predictive of chrysotile levels. Inhal Toxicol (2011) 2.62
Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis (2011) 2.35
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis (2009) 2.24
General mortality patterns in appalachian coal-mining and non-coal-mining counties. J Occup Environ Med (2014) 2.03
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis (2014) 1.86
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care (2010) 1.86
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther (2010) 1.83
Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 1.57
Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects. J Acquir Immune Defic Syndr (2009) 1.56
Long-term follow-up of the residents of the Three Mile Island accident area: 1979-1998. Environ Health Perspect (2003) 1.53
Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS (2014) 1.46
Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr (2014) 1.42
Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther (2009) 1.39
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis (2013) 1.36
Metabolic complications of HIV therapy in children. AIDS (2004) 1.28
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther (2011) 1.28
Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr (2008) 1.25
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr (2015) 1.25
Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. Antivir Ther (2011) 1.23
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis (2013) 1.23
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS (2013) 1.23
Fractures after antiretroviral initiation. AIDS (2012) 1.21
Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther (2011) 1.14
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease. J Acquir Immune Defic Syndr (2012) 1.12
Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc (2013) 1.09
Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children. Atherosclerosis (2010) 1.08
Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr (2013) 1.05
Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res (2012) 1.05
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS (2015) 1.05
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. J Acquir Immune Defic Syndr (2015) 1.05
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther (2012) 1.03
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals. J Acquir Immune Defic Syndr (2012) 1.03
Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared with healthy controls. Pediatr Infect Dis J (2010) 0.99
Arterial stiffness and gait speed in older adults with and without peripheral arterial disease. Am J Hypertens (2010) 0.99
Reevaluation of mortality risks from leukemia in the formaldehyde cohort study of the National Cancer Institute. Regul Toxicol Pharmacol (2004) 0.99
Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.99
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. J Antimicrob Chemother (2009) 0.99
Work in the metal industry and nasopharyngeal cancer mortality among formaldehyde-exposed workers. Regul Toxicol Pharmacol (2007) 0.98
Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol (2013) 0.97
Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J (2003) 0.96
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Ann Intern Med (2015) 0.95
A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy. AIDS Patient Care STDS (2012) 0.94
Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy. Antivir Ther (2012) 0.94
Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success. J Infect Dis (2011) 0.93
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. AIDS (2011) 0.93
Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV. AIDS (2016) 0.92
Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy. Int J Cardiol (2013) 0.92
Long-term health experience of jet engine manufacturing workers: VI: incidence of malignant central nervous system neoplasms in relation to estimated workplace exposures. J Occup Environ Med (2013) 0.91
Long-term health experience of jet engine manufacturing workers: VIII. glioblastoma incidence in relation to workplace experiences with parts and processes. J Occup Environ Med (2013) 0.91
Long-term health experience of jet engine manufacturing workers: VII: occupational exposures. J Occup Environ Med (2013) 0.91
C-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.91
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther (2013) 0.91
Incomplete follow-up in the National Cancer Institute's formaldehyde worker study and the impact on subsequent reanalyses and causal evaluations. Regul Toxicol Pharmacol (2010) 0.90
Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection. AIDS (2016) 0.90
Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial. AIDS Res Hum Retroviruses (2011) 0.89
Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine. J Acquir Immune Defic Syndr (2004) 0.88
Osteopenia and osteoporosis in patients with HIV: a review of current concepts. Curr Infect Dis Rep (2006) 0.88
Methodological issues in a retrospective cancer incidence study. Am J Epidemiol (2009) 0.88
Statins to improve cardiovascular outcomes in treated HIV infection. Curr Opin Infect Dis (2016) 0.87
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens. AIDS (2010) 0.87
Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS (2014) 0.87
Reevaluation of mortality risks from nasopharyngeal cancer in the formaldehyde cohort study of the National Cancer Institute. Regul Toxicol Pharmacol (2005) 0.87
Impact of randomized antiretroviral therapy initiation on glucose metabolism. AIDS (2014) 0.86
Childhood passive smoke exposure is associated with adult head and neck cancer. Cancer Epidemiol (2013) 0.86
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS (2013) 0.85
Mis-specified and non-robust mortality risk models for nasopharyngeal cancer in the National Cancer Institute formaldehyde worker cohort study. Regul Toxicol Pharmacol (2006) 0.85
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. J Acquir Immune Defic Syndr (2014) 0.84
Mortality patterns among workers exposed to arsenic, cadmium, and other substances in a copper smelter. Am J Ind Med (2009) 0.84
Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. J Int Assoc Physicians AIDS Care (Chic) (2007) 0.84
Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults. AIDS (2010) 0.83
A comparison of polycystic ovary syndrome and related factors between lesbian and heterosexual women. Womens Health Issues (2011) 0.83
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection. J Acquir Immune Defic Syndr (2016) 0.82
Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr (2015) 0.82
Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival. Infect Dis Clin North Am (2005) 0.82
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study. J Acquir Immune Defic Syndr (2006) 0.82
Cancer incidence among residents of the Three Mile Island accident area: 1982-1995. Environ Res (2011) 0.81
Short communication: initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimens. AIDS Res Hum Retroviruses (2012) 0.81
Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults. AIDS (2015) 0.81
First reported case of Neisseria meningitidis periorbital cellulitis associated with meningitis. Pediatrics (2005) 0.81
Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placebo. AIDS Res Hum Retroviruses (2010) 0.81
Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS (2016) 0.80
Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis (2015) 0.80
Pharyngeal cancer mortality among chemical plant workers exposed to formaldehyde. Toxicol Ind Health (2002) 0.80
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. J Acquir Immune Defic Syndr (2015) 0.79
De novo malignancies after intestinal and multivisceral transplantation. Transplantation (2004) 0.79
Newborns of preeclamptic women show evidence of sex-specific disparity in fetal growth. Gend Med (2012) 0.79
Cardiovascular disease risk in pediatric HIV: the need for population-specific guidelines. J Acquir Immune Defic Syndr (2011) 0.79
Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study. Antivir Ther (2013) 0.79
Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals. Curr HIV/AIDS Rep (2014) 0.79
Habitual nutrient intake in HIV-infected youth and associations with HIV-related factors. AIDS Res Hum Retroviruses (2014) 0.78
Vitamin D and bone loss in HIV. Curr Opin HIV AIDS (2016) 0.78
New entrants to HIV care are presenting only at marginally earlier stages of disease but may increasingly represent groups perceived at lower risk. J Int Assoc Physicians AIDS Care (Chic) (2005) 0.78
Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fat. HIV Clin Trials (2009) 0.78
The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine. Am J Ind Med (2003) 0.78
Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort. Antivir Ther (2009) 0.78
Long-term changes in carotid intima-media thickness among HIV-infected children and young adults. Antivir Ther (2013) 0.78